Healthcare Insights

 The global burn care centers market is entering a period of measured but sustained expansion, driven by technological advancements, rising incidences of burn injuries, and strengthening healthcare infrastructure across both developed and emerging regions. According to recent industry projections, the market is expected to grow at a CAGR of 4.6% , increasing from US$7.4 billion in 2023 to US$10.2 billion by the end of 2030 . This momentum reflects not only the increasing demand for specialized burn treatment services but also the ongoing investments made by healthcare systems to modernize patient care, enhance clinical outcomes, and adopt advanced wound-healing technologies. Rising Burn Incidence and Improved Access to Care Fuel Market Demand Burn injuries remain a significant global health concern, affecting millions annually and often requiring specialized medical attention. In low- and middle-income regions, burn injuries are more common due to factors such as open-fire cook...

 The global oncolytic virus immunotherapy market is entering a high-growth era driven by rapid advancements in cancer therapeutics, rising acceptance of immunotherapy approaches, and a robust pipeline of next-generation oncolytic viruses. Valued at US$245.3 million in 2025 , the market is projected to reach US$953.3 million by 2032 , expanding at an impressive CAGR of 21.4% during the forecast period. As precision oncology, viral engineering, and immune-modulating technologies converge, oncolytic viruses are emerging as a pivotal modality in cancer treatment strategies worldwide. Market Overview Oncolytic virus immunotherapy involves the use of genetically engineered or naturally occurring viruses that selectively infect and kill cancer cells while stimulating systemic antitumor immunity. Over the past decade, clinical progress and regulatory acceptance—highlighted by the approval of talimogene laherparepvec (T-VEC)—have validated this therapeutic class, encouraging investments...

 The global fibroblast growth factors (FGFs) market is entering a period of steady and significant growth, propelled by expanding biopharmaceutical research, rising demand for regenerative medicine, and increasing applications across oncology, wound healing, and chronic disease therapeutics. According to industry projections, the market is set to rise from US$301.9 million in 2025 to US$462.0 million by 2032 , reflecting a compound annual growth rate (CAGR) of 6.3% during the forecast period. FGFs, a family of proteins involved in crucial cellular processes—from angiogenesis and tissue repair to metabolism—are increasingly integrated into advanced therapeutic pipelines, including cell therapy, gene therapy, immuno-oncology, and tissue engineering. As healthcare systems globally embrace next-generation biologics and precision medicine, demand for high-quality, research-grade and GMP-grade FGFs continues to surge. Market Overview and Emerging Trends Between 2019 and 2024 , the ...

 The global flavors into over-the-counter (OTC) pharmaceuticals market is entering a transformative period, powered by shifting consumer preferences, advancements in flavor formulation technologies, and the rapid expansion of the self-medication trend. Valued at US$2.3 billion in 2025 , the market is projected to reach US$3.7 billion by 2032 , reflecting a robust CAGR of 6.8% during the forecast period. As taste continues to be a decisive factor in patient compliance—particularly in pediatric and geriatric populations—the importance of flavor innovation within the OTC drug sector is gaining unprecedented momentum. Market Overview OTC pharmaceuticals such as cough syrups, vitamin supplements, digestive aids, analgesics, and medicated lozenges rely heavily on flavor masking and enhancement to improve palatability. Bitter drug actives often pose a challenge, prompting manufacturers to adopt advanced technologies in flavor modulation and encapsulation. As global health awareness r...

 The global onychomycosis treatment market —covering therapies for fungal infections of the nails—is entering a period of steady evolution as rising disease prevalence, improved diagnostic capabilities, and expanding treatment innovations reshape demand worldwide. According to recent industry estimates, the market is expected to be valued at US$ 4.1 billion in 2025 and expand to US$ 5.8 billion by 2032 , reflecting a compound annual growth rate (CAGR) of 5.1% over the forecast period from 2025 to 2032. The forecast underscores not only the growing recognition of onychomycosis as a significant public health concern but also the increasing commercial potential of antifungal drugs, topical therapies, and laser-based treatment modalities. Rising Prevalence of Fungal Nail Infections Drives Market Expansion Onychomycosis affects millions worldwide and accounts for nearly half of all nail disorders globally. Factors such as diabetes, aging populations, greater participation in sport...

 The global physiotherapy equipment market is projected to experience robust growth over the coming years, rising from US$ 22.8 billion in 2025 to an estimated US$ 37.8 billion by 2032. This represents a compound annual growth rate (CAGR) of 6.8% during the forecast period, reflecting the increasing adoption of advanced physiotherapy devices across healthcare settings worldwide. The market’s growth is driven by factors such as rising prevalence of musculoskeletal disorders, increasing geriatric population, technological advancements in physiotherapy equipment, and growing awareness about non-invasive rehabilitation therapies. Market Overview and Dynamics Physiotherapy equipment encompasses a wide range of devices used for rehabilitation, pain management, and functional recovery in patients suffering from orthopedic, neurological, cardiopulmonary, and other health conditions. The rising burden of chronic diseases, coupled with a shift toward outpatient rehabilitation and home-bas...

 The United States assisted reproductive technology (ART) market is poised for remarkable growth, projected to reach a valuation of US$11.3 billion by 2031. This expansion reflects a robust compound annual growth rate (CAGR) of 17.8% during the forecast period from 2024 to 2031. As demand for fertility treatments rises due to changing demographics, delayed parenthood, and technological advancements, the market landscape is witnessing significant developments in both clinical applications and procedural innovations. Market Overview Assisted reproductive technology encompasses a wide array of medical procedures designed to aid individuals and couples struggling with infertility. Techniques such as in vitro fertilization (IVF) and artificial insemination have become increasingly prevalent, offering hope to millions of patients. The US, as a leader in healthcare innovation and medical infrastructure, has seen a growing acceptance of ART procedures driven by greater awareness, access...